Scottish company secures £4.2m to advance 3D-printed micro-tumour tech

Carcinotech has gained funding to enter the North American market with the company's pioneering 3D-printed tumours for cancer treatments.

Alexander Love2 2 月 20241 archived media files

Carcinotech has gained funding to enter the North American market with the company’s pioneering 3D-printed tumours for cancer treatments.